AG
SRNE

Aperio Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Aperio Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$248K Sell
2020
Q3 		$482K Buy
2020
Q2 		$175K Buy
2020
Q1 		$26K Buy
2019
Q3 		– Sell
2019
Q2 		$3K Buy